ATE267185T1 - Therapeutisch wirksame linksdrehende und rechtsdrehende 1-((4-chlorphenyl)phenylmethyl) piperazine - Google Patents

Therapeutisch wirksame linksdrehende und rechtsdrehende 1-((4-chlorphenyl)phenylmethyl) piperazine

Info

Publication number
ATE267185T1
ATE267185T1 AT99109564T AT99109564T ATE267185T1 AT E267185 T1 ATE267185 T1 AT E267185T1 AT 99109564 T AT99109564 T AT 99109564T AT 99109564 T AT99109564 T AT 99109564T AT E267185 T1 ATE267185 T1 AT E267185T1
Authority
AT
Austria
Prior art keywords
ethyl
wotting
chlorphenyl
phenylmethyl
piperazine
Prior art date
Application number
AT99109564T
Other languages
English (en)
Inventor
Eric Cossement
Guy Bodson
Jean Gobert
Original Assignee
Ucb Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Sa filed Critical Ucb Sa
Application granted granted Critical
Publication of ATE267185T1 publication Critical patent/ATE267185T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26—Sulfur atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
AT99109564T 1993-03-15 1994-03-09 Therapeutisch wirksame linksdrehende und rechtsdrehende 1-((4-chlorphenyl)phenylmethyl) piperazine ATE267185T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939305282A GB9305282D0 (en) 1993-03-15 1993-03-15 Enantiomers of 1-(4-chlorophenyl)phenylmethyl)-4-(4-methylphenyl)sulphonyl)piperazine

Publications (1)

Publication Number Publication Date
ATE267185T1 true ATE267185T1 (de) 2004-06-15

Family

ID=10732080

Family Applications (2)

Application Number Title Priority Date Filing Date
AT94870043T ATE193889T1 (de) 1993-03-15 1994-03-09 Enantiomere von 1-((4-chlorophenyl)phenylmethyl)- 4-((4-methylphenyl)sulfonyl)piperazin
AT99109564T ATE267185T1 (de) 1993-03-15 1994-03-09 Therapeutisch wirksame linksdrehende und rechtsdrehende 1-((4-chlorphenyl)phenylmethyl) piperazine

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT94870043T ATE193889T1 (de) 1993-03-15 1994-03-09 Enantiomere von 1-((4-chlorophenyl)phenylmethyl)- 4-((4-methylphenyl)sulfonyl)piperazin

Country Status (23)

Country Link
US (17) US5478941A (de)
EP (3) EP0955295B1 (de)
JP (3) JP3267434B2 (de)
KR (1) KR100322415B1 (de)
AT (2) ATE193889T1 (de)
AU (1) AU678426B2 (de)
CA (2) CA2118859C (de)
DE (2) DE69433802T2 (de)
DK (1) DK0617028T3 (de)
ES (2) ES2221262T3 (de)
FI (3) FI105477B (de)
GB (1) GB9305282D0 (de)
GR (1) GR3034340T3 (de)
HU (1) HU219230B (de)
NO (2) NO305908B1 (de)
NZ (1) NZ260062A (de)
PL (1) PL178546B1 (de)
PT (1) PT617028E (de)
RU (1) RU2118320C1 (de)
SG (1) SG43683A1 (de)
SI (2) SI0955295T1 (de)
TW (1) TW237452B (de)
ZA (1) ZA941724B (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5831066A (en) 1988-12-22 1998-11-03 The Trustees Of The University Of Pennsylvania Regulation of bcl-2 gene expression
DE10199031I2 (de) * 1992-09-24 2004-09-23 Sepracor Inc Verwendung von (-) Cetrizin zur Behandlung allergischer Rhinitis und Asthma.
EP0885611A3 (de) * 1992-09-24 1999-01-07 Sepracor, Inc. Verfahren und Zusammensetzungen zur Behandlung von allergischen Krankheiten unter Verwendung von optisch reinen (+) Cetirizin
GB9305282D0 (en) * 1993-03-15 1993-05-05 Ucb Sa Enantiomers of 1-(4-chlorophenyl)phenylmethyl)-4-(4-methylphenyl)sulphonyl)piperazine
EP0690051B1 (de) * 1994-01-14 2001-07-18 Azwell Inc. Diazacycloalkanalkylsulfonamid-derivat
CN1058638C (zh) * 1995-06-27 2000-11-22 中国药品生物制品检定所 胞内分枝杆菌变态反应原提取方法
DE69818079T2 (de) 1997-06-04 2004-06-03 Azwell Inc. Verfahren zur herstellung von piperazinsulfonamid-derivaten und ihren salzen
US6384038B1 (en) * 1998-04-14 2002-05-07 Sepracor Inc. Methods and compositions using cetirizine in combination with leukotriene inhibitors or decongestants
IL124195A (en) * 1998-04-23 2000-08-31 Chemagis Ltd Process for the preparation of esters of 2-¬4-¬4-chlorophenyl¾phenylmethyl¾-1-piperazinyl¬ethoxy¾acetic acid
US6432961B1 (en) * 1998-08-18 2002-08-13 Ucb S.A. Method for preventing the onset of asthma
PE20001566A1 (es) * 1999-03-26 2001-02-05 Ucb Sa Piperazinas 1,4-sustituidas, piperidinas 1,4-sustituidas y 4-alquilidenilpiperidinas 1-sustituidas
HRP20020470B1 (hr) * 1999-11-30 2009-04-30 Egis Gy�gyszergy�r RT POSTUPAK PRIREĐIVANJA {2-[4-(α-FENIL-p-KLORBENZIL)-PIPERAZIN-1-IL]ETOKSI} OCTENE KISELINE I NOVIH INTERMEDIJERA
JP2002249487A (ja) 2001-02-22 2002-09-06 Sumitomo Chem Co Ltd 4−(tert−ブトキシカルボニル)ピペラジン誘導体、その光学活性な酸付加塩、それらの製造法、およびそれらを用いる光学活性な1−[(置換フェニル)フェニルメチル]ピペラジンの製造法。
US7199241B1 (en) 2001-05-29 2007-04-03 Ucb, S.A. Process for preparing (S) and (R)-2-[4-(4-chlorobenzhydryl)piperazin-1-yl]-ethoxyacetamide
US6977301B1 (en) 2001-05-29 2005-12-20 Ucb, S.A. Process for preparing (S) and (R)—2-[4-(4-chlorobenzhydryl)piperazin-1-yl]-ethoxyacetamide
AR039156A1 (es) * 2002-03-28 2005-02-09 Novartis Ag Amidas del acido piperidinilamino sulfamico o piperazinil sulfamico y su uso para la manufactura de un medicamento en enfermedades mediadas por la accion de la sulfatasa esteroide
US20040186112A1 (en) * 2002-12-04 2004-09-23 Dr. Reddy's Laboratories Limited Polymorphic forms of dihydrochloride salts of cetirizine and processes for preparation thereof
WO2004084836A2 (en) * 2003-03-20 2004-10-07 Rinat Neuroscience Corp. Methods for treating taxol-induced gut disorder
US7577727B2 (en) * 2003-06-27 2009-08-18 Newisys, Inc. Dynamic multiple cluster system reconfiguration
KR100503443B1 (ko) 2004-02-02 2005-07-22 한림제약(주) 광학적으로 활성인 세티리진 또는 그의 염의 제조방법
CN101128446B (zh) * 2005-03-03 2010-12-08 Ucb法奇姆股份有限公司 焦谷氨酸盐及其在用于合成右旋西替利嗪和左旋西替利嗪的中间体的光学拆分中的用途
HU227074B1 (en) * 2005-12-08 2010-06-28 Egis Gyogyszergyar Nyrt An optically active carbamic acid derivative, method for producing the same and use as a pharmaceutical intermediate
EP2121643B1 (de) * 2007-03-12 2013-10-23 Krka, tovarna zdravil, d.d., Novo mesto Neues verfahren zur herstellung von levocetirizin und zwischenprodukte davon
US8084606B2 (en) * 2007-06-15 2011-12-27 Symed Labs Limited Process for preparation of substantially optically pure levorotatory and dextrorotatory enantiomers of cetirizine using novel intermediates
US20090062305A1 (en) * 2007-08-29 2009-03-05 Protia, Llc Deuterium-enriched cetirizine
US20090082364A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched levocedtirizine
KR101427100B1 (ko) 2007-10-23 2014-08-08 주식회사 씨트리 광학활성을 갖는 1-[(4-클로로페닐)페닐메틸]-피페라진의제조방법
US7989623B2 (en) * 2007-11-21 2011-08-02 Synthon Bv Process for making n-(diphenylmethyl)piperazines
PL2062881T3 (pl) 2007-11-21 2011-07-29 Synthon Bv Sposób wytwarzania N-(difenylometylo)piperazyn
KR100954755B1 (ko) * 2007-12-17 2010-04-27 한미약품 주식회사 (r)-(-)-1-[(4-클로로페닐)페닐메틸]피페라진의 제조방법
CA2724887A1 (en) * 2008-06-02 2009-12-10 Cipla Limited Processes for the synthesis of levocetirizine and intermediates for use therein
KR100998067B1 (ko) 2008-09-08 2010-12-03 주식회사 삼오제약 비스(1-[(4-클로로페닐)페닐메틸]피페라진)-2,3-디벤조일 타르타르산 신규 중간체 염 및 이를 이용한 광학 활성적으로 순수한 1-[(4-클로로페닐)페닐메틸]피페라진을 분리하는 분리방법
US20100145049A1 (en) * 2008-11-21 2010-06-10 Jie Zhu Process for making n-(diphenylmethyl)piperazines
CN102459210B (zh) * 2009-04-22 2015-09-02 埃克希金医药品有限公司 芳基磺酰胺ccr3拮抗剂
CN101928223A (zh) * 2009-06-26 2010-12-29 华东理工大学 一种(r)-(-)-4-氯二苯甲胺的拆分方法
WO2012101475A1 (en) 2011-01-27 2012-08-02 Jubilant Life Sciences Limited An improved process for the preparation of antihistaminic drugs via a novel carbamate intermediate
KR101418404B1 (ko) 2012-01-06 2014-07-10 한미약품 주식회사 레보세티리진 또는 이의 약학적으로 허용가능한 염 및 몬테루카스트 또는 이의 약학적으로 허용가능한 염을 함유하는 안정한 경구투여용 약학 제제
EP2838521A4 (de) 2012-04-16 2015-03-11 Zemtsov Entpr Llc Formulierungen und verfahren zur behandlung von wunden und entzündlichen hautzuständen
CN103613567A (zh) * 2012-11-09 2014-03-05 焦作福瑞堂制药有限公司 盐酸氯环利嗪的合成工艺
KR102226833B1 (ko) 2013-06-28 2021-03-12 한미약품 주식회사 레보세티리진 및 몬테루카스트를 포함하는 안정성이 개선된 복합 과립 제형
CN104045607B (zh) * 2014-05-21 2016-04-13 丽珠医药集团股份有限公司 一种盐酸西替利嗪的纯化方法
CN111205247B (zh) * 2020-04-22 2020-08-14 湖南九典宏阳制药有限公司 左旋西替利嗪的制备方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA568380A (en) * 1959-01-06 Morren Henri Ethers of piperazine and method of their preparation
BE540057A (de) *
US2709169A (en) * 1955-05-24 X c chs
US2899436A (en) * 1959-08-11 chjch
BE523901A (de) *
GB752331A (en) * 1948-09-30 1956-07-11 Abbott Lab Improvements in or relating to n, n-disubstituted piperazines and process of preparing the same
US2861072A (en) * 1952-07-19 1958-11-18 Abbott Lab Preparation of piperazine derivatives
US2709167A (en) * 1952-09-10 1955-05-24 Geigy Ag J R Chromium-containing monoazo dyestuffs
US2897436A (en) * 1954-09-29 1959-07-28 Amchem Prod Indicating and control apparatus for electrolyte concentration and the like
US3406174A (en) * 1964-10-23 1968-10-15 Sandoz Ag Benzylsulfamides
NO155805C (no) * 1981-02-06 1987-06-10 Ucb Sa Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2-(4-(difenylmethyl)-1-piperazinyl)-eddiksyrer og deres amider og ikke-toksiske salter.
US4749700A (en) * 1984-10-23 1988-06-07 Nastech Pharmaceutical Co, Inc. Novel methods of administering antihistamines, antinausea and antiemetic pharmaceutical agents and novel dosage forms containing same
DE3640247A1 (de) * 1986-11-25 1988-05-26 Basf Ag Fungizide cyclohexylamine
US4975426A (en) * 1987-06-08 1990-12-04 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
US5234957A (en) * 1991-02-27 1993-08-10 Noven Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
JP2559463B2 (ja) * 1988-06-01 1996-12-04 ダイセル化学工業株式会社 不斉中心に2個の芳香族基を有する化合物の光学分割方法
JPH0239947A (ja) * 1988-07-29 1990-02-08 Seikosha Co Ltd 印字ヘッド
GB8827391D0 (en) * 1988-11-23 1988-12-29 Ucb Sa Process for preparation of 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-pipera-zinyl)ethoxy)-acetic acid & its dihydrochloride
US4882432A (en) * 1989-01-09 1989-11-21 American Home Products Corporation Polycyclic-carbamic acid piperazinoalkyl esters and amides
US5087627A (en) * 1989-03-15 1992-02-11 Santen Pharmaceutical Co., Ltd. Agent for treatment of disorders of the cerebro-neural transmission system
EP0475251B1 (de) * 1990-09-10 1997-03-26 Mitsubishi Denki Kabushiki Kaisha Kodiervorrichtung für digitale Bilddaten
EP0885611A3 (de) 1992-09-24 1999-01-07 Sepracor, Inc. Verfahren und Zusammensetzungen zur Behandlung von allergischen Krankheiten unter Verwendung von optisch reinen (+) Cetirizin
DE10199031I2 (de) 1992-09-24 2004-09-23 Sepracor Inc Verwendung von (-) Cetrizin zur Behandlung allergischer Rhinitis und Asthma.
GB9305282D0 (en) * 1993-03-15 1993-05-05 Ucb Sa Enantiomers of 1-(4-chlorophenyl)phenylmethyl)-4-(4-methylphenyl)sulphonyl)piperazine

Also Published As

Publication number Publication date
HUT70959A (en) 1995-11-28
GR3034340T3 (en) 2000-12-29
DE69424893T2 (de) 2000-10-12
NO305908B1 (no) 1999-08-16
DE69424893D1 (de) 2000-07-20
US20040122023A1 (en) 2004-06-24
NO306616B1 (no) 1999-11-29
US20070142400A1 (en) 2007-06-21
ATE193889T1 (de) 2000-06-15
DE69433802T2 (de) 2005-05-12
TW237452B (de) 1995-01-01
JPH072816A (ja) 1995-01-06
FI941134L (fi) 1994-09-16
NO940881L (no) 1994-09-16
HU9400727D0 (en) 1994-06-28
PT617028E (pt) 2000-11-30
AU5777194A (en) 1994-09-22
CA2443216C (en) 2007-05-08
FI105914B (fi) 2000-10-31
SI0617028T1 (en) 2000-10-31
DE69433802D1 (de) 2004-06-24
US20050182070A1 (en) 2005-08-18
US20060252934A1 (en) 2006-11-09
NO990351D0 (no) 1999-01-26
RU2118320C1 (ru) 1998-08-27
ES2147569T3 (es) 2000-09-16
AU678426B2 (en) 1997-05-29
CA2443216A1 (en) 1994-09-16
CA2118859A1 (en) 1994-09-16
US20030105113A1 (en) 2003-06-05
US20060229319A1 (en) 2006-10-12
US20040122021A1 (en) 2004-06-24
US20030105112A1 (en) 2003-06-05
US20050176732A1 (en) 2005-08-11
EP0955295B1 (de) 2004-05-19
JP3880842B2 (ja) 2007-02-14
HK1024232A1 (en) 2000-10-05
PL178546B1 (pl) 2000-05-31
ES2221262T3 (es) 2004-12-16
JP2006342190A (ja) 2006-12-21
US20050182069A1 (en) 2005-08-18
HU219230B (en) 2001-03-28
US6436942B1 (en) 2002-08-20
FI105915B (fi) 2000-10-31
US20030204089A1 (en) 2003-10-30
GB9305282D0 (en) 1993-05-05
SG43683A1 (en) 1997-11-14
ZA941724B (en) 1994-10-13
EP0955295A1 (de) 1999-11-10
US5703082A (en) 1997-12-30
US5478941A (en) 1995-12-26
EP0617028A1 (de) 1994-09-28
US20040072845A1 (en) 2004-04-15
KR100322415B1 (ko) 2002-06-20
FI19991729L (fi) 1999-08-16
NO940881D0 (no) 1994-03-11
EP1413307A1 (de) 2004-04-28
US5792770A (en) 1998-08-11
CA2118859C (en) 2004-07-13
US20060229320A1 (en) 2006-10-12
NO990351L (no) 1999-01-26
DK0617028T3 (da) 2000-09-04
FI105477B (fi) 2000-08-31
SI0955295T1 (en) 2004-10-31
EP0617028B1 (de) 2000-06-14
JP2002201187A (ja) 2002-07-16
FI941134A0 (fi) 1994-03-10
JP3267434B2 (ja) 2002-03-18
FI19991730L (fi) 1999-08-16
NZ260062A (en) 1995-09-26

Similar Documents

Publication Publication Date Title
DE69433802D1 (de) Therapeutisch wirksame linksdrehende und rechtsdrehende 1-((4-Chlorphenyl)phenylmethyl) Piperazine
FI913142A0 (fi) Migraenfoerhindrande alkoxipyrimidinderivat.
ATE230757T1 (de) Verabreichung von peptidylheterocyclen zur behandlung von thrombin in zusammenhang stehenden krankheiten
BR9205811A (pt) Derivados heterociclicos de aminas ciclicas
BR9508655A (pt) Composição farmacêutica aquosa estéril
RU93043528A (ru) Моногидрат 5-(2-(4-(1,2-бензотиазол-3-ил)-1-пиперазинил)этил)-6-хлор-1,3-дигидро-2н-индол-2-он хлоргидрата, способ его получения, фармацевтическая композиция, способ лечения
ATE263564T1 (de) Verwendung von 1-(4-(5-cyanoindol-3yl)butyl)-4-(2-carbamoylben ofuran-5-yl)piperazin und dessen physiologisch akzeptablen salzen zur behandlung von bipolaren krankheiten und manie
FI954580A7 (fi) HIV-proteaasin estäjiä farmaseuttisissa yhdistelmissä käytettäväksi AIDSin hoitoon
NO20022525D0 (no) Farmasöytiske formuleringer inneholdende zolmitriptan
KR970700372A (ko) 바이폴라 트랜지스터의 베이스 형성시의 경사 주입 사용법(use of oblique implantation in forming base of bipolar transistor)
EA200400253A1 (ru) Применение соединения bibn4096bs в комбинации с другими лекарственными веществами против мигрени для лечения мигрени
NO960775L (no) Anvendelse av kinoksaliner i kombinasjon med proteaseinhibitorer som legemiddel for behandling av AIDS og/eller HIV-infeksjoner
NO971261D0 (no) Kinoksalin-derivater nyttige innen terapi
YU67402A (sh) Nova upotreba (r)-(-)-2-/5-(4-fluorofenil)-3- piridilmetilaminometil/-hromana i njegovih fiziološki prihvatljivih soli
DE3777665D1 (de) Heptanoyl-glu-asp-ala-amino-saeure-immunstimulanten.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0955295

Country of ref document: EP

REN Ceased due to non-payment of the annual fee